This article is a preview of The Logic’s Daily Briefing newsletter, sent every weekday. Sign up for a free trial.
Shares in Dialogue Health Technologies surged on their first day on the Toronto Stock Exchange, trading well above their IPO price of $12, which secured total gross proceeds of about $100 million. It underscores the Montreal-based telemedicine startup’s rise, as well as the suddenly important role the sector plays in these COVID-19-addled times. The Logic spoke with Dialogue CEO Cherif Habib about the company, its Montreal roots, and whether it can sustain its meteoric growth.
